Bastien Jamet

Nantes, 44000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Bimodal PET/CT and PET/MRI imaging in multiple myeloma/prostate cancer restaging and response to BCMA-targeted CAR T-therapy assessment.

Bimodal PET/CT and PET/MRI imaging in multiple myeloma/prostate cancer restaging and response to BCMA-targeted CAR T-therapy assessment.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 10, 2026

French recommendations for the use of Imaging in Giant Cell Arteritis.

French recommendations for the use of Imaging in Giant Cell Arteritis.

Journal: Joint bone spine

Published: February 01, 2026

Optimal acquisition time of [68Ga]Ga-PentixaFor PET/CT for initial staging of multiple myeloma: an ancillary study to the PentiMyelo protocol.

Optimal acquisition time of [68Ga]Ga-PentixaFor PET/CT for initial staging of multiple myeloma: an ancillary study to the PentiMyelo protocol.

Journal: EJNMMI research

Published: January 08, 2026

FDG-PET medullary total tumor volume highlights high-risk patients with newly diagnosed multiple myeloma in CASSIOPEIA trial.

FDG-PET medullary total tumor volume highlights high-risk patients with newly diagnosed multiple myeloma in CASSIOPEIA trial.

Journal: Blood advances

Published: December 22, 2025

Prognostic Value of Cranial Arteries Involvement on 18 F-FDG PET/CT at Giant Cell Arteritis Diagnosis in a Multicenter Cohort.

Prognostic Value of Cranial Arteries Involvement on 18 F-FDG PET/CT at Giant Cell Arteritis Diagnosis in a Multicenter Cohort.

Journal: Clinical nuclear medicine

Published: December 03, 2025

Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial.

Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial.

Journal: Blood

Published: May 21, 2025

Simultaneous whole-body multi-parametric 2-[18F]FDG-PET/MRI in smoldering multiple myeloma assessment: diagnostic and prognostic impact.

Simultaneous whole-body multi-parametric 2-[18F]FDG-PET/MRI in smoldering multiple myeloma assessment: diagnostic and prognostic impact.

Journal: Leukemia

Published: April 29, 2025

Secukinumab after tocilizumab failure in giant cell arteritis.

Secukinumab after tocilizumab failure in giant cell arteritis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: April 22, 2025

Mixed neuroendocrine non-neuroendocrine neoplasm combining neuroendocrine tumor with hepatocellular carcinoma in the context of multiple endocrine neoplasia type 1.

Mixed neuroendocrine non-neuroendocrine neoplasm combining neuroendocrine tumor with hepatocellular carcinoma in the context of multiple endocrine neoplasia type 1.

Journal: Clinics and research in hepatology and gastroenterology

Published: January 08, 2025

Unusual Sole Extramedullary Diffuse Kidney Involvement in Multiple Myeloma Initial Workup Using 2-[ 18 F]FDG-PET/CT Imaging.

Unusual Sole Extramedullary Diffuse Kidney Involvement in Multiple Myeloma Initial Workup Using 2-[ 18 F]FDG-PET/CT Imaging.

Journal: Clinical nuclear medicine

Published: November 25, 2024

Case Report of Concomitant Diagnosis of Locally Advanced Intrahepatic Cholangiocarcinoma and Solitary Plasmacytoma of T11 Vertebra: Impact on Diagnostic and Clinical Management.

Case Report of Concomitant Diagnosis of Locally Advanced Intrahepatic Cholangiocarcinoma and Solitary Plasmacytoma of T11 Vertebra: Impact on Diagnostic and Clinical Management.

Journal: Current oncology (Toronto, Ont.)

Published: August 02, 2024

Coronary Arteries Involvement in Giant Cell Arteritis Diagnosis Using 2-[ 18 F]FDG-PET/CT.

Coronary Arteries Involvement in Giant Cell Arteritis Diagnosis Using 2-[ 18 F]FDG-PET/CT.

Journal: Clinical nuclear medicine

Published: July 21, 2024

Showing 1-12 of 42

Last Updated: 09/26/2026